Published in Blood Weekly, February 16th, 2006
"The rapidly expanding field of stem cell research offers the potential to develop therapeutic agents to treat diseases such as Parkinson, diabetes and heart disease," scientists in England report in their review.
"It is important that stem cell lines derived from quality-controlled and well-characterized cell banks should be made available to both the scientific and clinical communities to promote high-quality research and development. The requirement in the United Kingdom (U.K.) for rigorous regulation of the procurement...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.